There is a common misconception that a remote-first approach will result in reduced engagement, higher costs, and longer timelines. When it comes to remote workplaces and decentralized clinical trials – it’s not an all-or-nothing approach. Instead – it is a balance of onsite and virtual elements to provide people with choice. Listen to our CEO & Founder Derk Arts share his thoughts about why remote-first is the only way forward and what we can lean into right now to achieve it.

Share article